• ArrayPharmacy
  • call for care 214.379.2700

    Choice Cancer Care is here for you 9AM – 5PM Monday – Friday

    Inquiring after hours? Complete our contact form and we will be in touch as soon as possible.

    Call

  • Patientportal

    Access Your Portal To Health at Choice Cancer Care.

    Learn more about becoming a CCC Patient, including insurance information and patient rights, or login to access your personal portal for in-depth information about your health.

    LoginSign UpLearn More

  • get a second opinion

    Recent Diagnosis? Gain Confidence With A Second Opinion.

    Find out what to ask your doctor, what a second opinion could mean for you, and take the steps to get you on the right path to treat your cancer.

    Complete this form for a no obligation consultation:









  • certified

    Choice Cancer Care is proud to be recognized by the Quality Oncology Practice Initiative (QOPI®) for excellence in quality, and safety in the administration of cancer care.

    Learn More

New Lung Cancer Detection Method Shows Potential

While traditional methods for detecting lung cancer use scanning technologies, there have been developments in using exhaled breath. When analyzed by chromatographic and mass spectrometric studies, the detection of volatile organic compounds (VOCs) specifically seen in patients, like styrene, have been in accordance with traditional methods and the results obtained are 85 percent accurate. Inbar Nardi-Agmon, MD, of Sheba Medical Center in Tel Aviv, and his colleagues carried out a study to test this theory. The data was collected over increments, with breath samples being taken on average, every 6 weeks.

  • 1 group: 143 breath-exhaled breath samples from 39 patients with advanced lung cancer were collected and analyzed by gas chromatography-mass spectrometry. There was a search for VOCs which had been previously identified- styrene, Dodecan 4-methyl, and ɑ-Phellandrene.
  • 85 percent accuracy: Traditional CT scanning and RECIST served as the standard to monitor treatment efficacy. It was found that there was 85 percent success in monitoring disease presence, and for the cases wrongly identified, the researchers noted that some in that group may have been categorized incorrectly at initial assessment or the time interval between sampling may have been too long.
  • 17 compound markers indicative of lung cancer found: Another study, conducted by Rosamaria Capuano, of the University of Rome Tor Vergata, and colleagues identified a total of 17 compounds as related to lung cancer by comparison with existing mass spectral libraries. Some of them have been found as characteristic VOCs in lung cancer.

These two studies, taken in conjunction, have led the researchers to conclude that breath analysis is an area of research with great potential in cancer screening. With further advancements and in-depth research, these breath tests may have the potential to improve cancer screening methods, making it possible to detect it in early stages.